We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+8.55%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$11.4B
AUM Growth
+$476M
Cap. Flow
-$300M
Cap. Flow %
-2.64%
Top 10 Hldgs %
22.33%
Holding
2,538
New
224
Increased
309
Reduced
1,136
Closed
102

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$24.1M
2
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$21.3M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$13.2M
4
PATH icon
UiPath
PATH
+$10.4M
5
AZPN
ASPEN TECHNOLOGY INC
AZPN
+$4.67M

Top Sells

Rank Stock Value
1
MPLX icon
MPLX
MPLX
+$20.7M
2
AAPL icon
Apple
AAPL
+$16M
3
BSV icon
Vanguard Short-Term Bond ETF
BSV
+$15.6M
4
MSFT icon
Microsoft
MSFT
+$13M
5
WMB icon
Williams Companies
WMB
+$9.28M

Sector Composition

Rank Sector Weight
1 Technology 20.93%
2 Financials 13.29%
3 Healthcare 12.64%
4 Consumer Discretionary 11.46%
5 Industrials 9.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CCBG icon
2326
Capital City Bank Group
CCBG
$896M
$149K ﹤0.01%
5,769
– –
RM icon
2327
Regional Management Corp
RM
$297M
$149K ﹤0.01%
+3,196
New +$138K
ZVRA icon
2328
Zevra Therapeutics
ZVRA
$679M
$149K ﹤0.01%
+11,600
New +$125K
BSRR icon
2329
Sierra Bancorp
BSRR
$528M
$149K ﹤0.01%
5,841
– –
RVI
2330
DELISTED
Retail Value Inc. Common Shares
RVI
$148K ﹤0.01%
+74,278
New +$132K
APLT
2331
DELISTED
Applied Therapeutics
APLT
$148K ﹤0.01%
+7,129
New +$135K
CZNC icon
2332
Citizens & Northern Corp
CZNC
$465M
$148K ﹤0.01%
+6,038
New +$148K
CLPT icon
2333
ClearPoint Neuro
CLPT
$463M
$147K ﹤0.01%
+7,721
New +$149K
KALV
2334
DELISTED
KalVista Pharmaceuticals
KALV
$147K ﹤0.01%
6,130
– –
UVE icon
2335
Universal Insurance Holdings
UVE
$1.18B
$147K ﹤0.01%
10,579
+5,542
+110% +$77.8K
ORMP icon
2336
Oramed Pharmaceuticals
ORMP
$178M
$147K ﹤0.01%
+10,953
New +$125K
FOR icon
2337
Forestar Group
FOR
$1.49B
$146K ﹤0.01%
6,983
– –
LCTX icon
2338
Lineage Cell Therapeutics
LCTX
$278M
$144K ﹤0.01%
+50,559
New +$131K
FRST icon
2339
Primis Financial Corp
FRST
$411M
$144K ﹤0.01%
+9,422
New +$141K
DHIL
2340
DELISTED
Diamond Hill
DHIL
$143K ﹤0.01%
856
-690
-45% -$118K
NPK icon
2341
National Presto Industries
NPK
$998M
$143K ﹤0.01%
1,408
-1,164
-45% -$120K
BTAI icon
2342
BioXcel Therapeutics
BTAI
$32.7M
$143K ﹤0.01%
308
– –
KODK icon
2343
Kodak
KODK
$992M
$143K ﹤0.01%
+17,157
New +$135K
PASG icon
2344
Passage Bio
PASG
$14.8M
$142K ﹤0.01%
537
– –
STGW icon
2345
Stagwell
STGW
$2.29B
$142K ﹤0.01%
+24,232
New +$113K
NOTV
2346
DELISTED
Inotiv
NOTV
$142K ﹤0.01%
+5,305
New +$133K
MSGN
2347
DELISTED
MSG Networks Inc.
MSGN
$141K ﹤0.01%
9,674
– –
CNTY icon
2348
Century Casinos
CNTY
$34.3M
$141K ﹤0.01%
+10,495
New +$137K
TA
2349
DELISTED
TravelCenters of America LLC
TA
$141K ﹤0.01%
+4,817
New +$134K
MCFT icon
2350
MasterCraft Boat Holdings
MCFT
$600M
$141K ﹤0.01%
5,356
– –
92 93
94
95 96

Similar funds

SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BG
Bahl & Gaynor Cincinnati, Ohio $19.8B AUM 19.53% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

MetLife Investment Management's Q2 2021 Portfolio in Review

As of Q2 2021, MetLife Investment Management held 2,538 positions worth $11.4B, up 4.4% from $10.9B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

MetLife Investment Management's Q2 2021 filing shows 224 new, 309 increased, 1,136 reduced and 102 closed positions. Its largest new stake was UiPath: 142,126 shares worth $9.65M. The largest sale was MPLX, an estimated $20.7M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q2 2021 buy was UiPath: 142,126 shares worth $9.65M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $24.1M increase.
  • MetLife Investment Management's biggest Q2 2021 reduction was Apple, cutting an estimated $16M.
  • MetLife Investment Management fully exited MPLX in Q2 2021, selling an estimated $20.7M.
  • MetLife Investment Management's ten largest holdings make up 22% of its $11.4B portfolio in Q2 2021.
  • MetLife Investment Management opened 224 new positions and closed 102 in Q2 2021.
  • MetLife Investment Management's portfolio value rose 4.4% quarter-over-quarter to $11.4B.

Based on MetLife Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.